Valeant Pharmaceuticals International Financial Analyst Salaries in Los Angeles
The average Valeant Pharmaceuticals International Financial Analyst in Los Angeles earns an estimated $89,326 annually, which includes an estimated base salary of $76,925 with a $12,401 bonus. Valeant Pharmaceuticals International's Financial Analyst compensation is $1,927 more than the US average for a Financial Analyst. Financial Analyst salaries at Valeant Pharmaceuticals International in Los Angeles can range from $52,000 - $185,000.
In Los Angeles, The Finance Department at Valeant Pharmaceuticals International earns $2,225 more on average than the Marketing Department.
Last updated 2 years ago.
- $76,925
- avg. base
- $12,401
- avg. bonus
Financial Analyst Salaries at Valeant Pharmaceuticals International
In Los Angeles, Financial Analysts earn $5,009 more than Financial Analysts, and $1,830 less than Business Analysts.
Compensation at Valeant Pharmaceuticals International by Department
In Los Angeles, The Finance Department averages $2,225 more than the Marketing Department, and $1,289 less than the Sales Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
How Financial Analysts at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Financial Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Financial Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
